Join
Live feed
·
INSIDERFilingvia Quantisnow
VYNE Therapeutics Inc. logo

PRESIDENT AND CEO Domzalski David covered exercise/tax liability with 935 shares, decreasing direct ownership by 0.19% to 497,654 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VYNE· VYNE Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNE (VYNE Therapeutics Inc.) and more on Quantisnow.